Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 4, 2015, Pages 904-913

  Larose, Marie Chantal ^a   Chakir, Jamila ^a   Archambault, Anne Sophie ^a   Joubert, Philippe ^a   Provost, Véronique ^a   Laviolette, Michel ^a   Flamand, Nicolas ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Asthma; bronchial epithelial cells; bronchial mucosa; CCL26; chemokine; eotaxin; IL 13; inflammation; severe asthma

Indexed keywords

EOTAXIN 3; INTERLEUKIN 13; MAJOR BASIC PROTEIN; BETA CHEMOKINE; CCL26 PROTEIN, HUMAN;

ADULT; AIRWAY; ARTICLE; ASTHMA; BRONCHIAL EPITHELIAL CELL; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEVERE EOSINOPHILIC ASTHMA; SPUTUM ANALYSIS; BRONCHUS; CELL CULTURE; DISEASE COURSE; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ADULT; ASTHMA; BRONCHI; CELLS, CULTURED; CHEMOKINES, CC; DISEASE PROGRESSION; EOSINOPHIL MAJOR BASIC PROTEIN; EOSINOPHILIA; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-13; MALE;

EID: 84943452766     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.02.039     Document Type: Article

References (66)

1. J. Bousquet, P.K. Jeffery, W.W. Busse, M. Johnson, and A.M. Vignola Asthma. From bronchoconstriction to airways inflammation and remodeling Am J Respir Crit Care Med 161 2000 1720 1745
2. H.F. Rosenberg, S. Phipps, and P.S. Foster Eosinophil trafficking in allergy and asthma J Allergy Clin Immunol 119 2007 1303 1310
3. D.G. Robertson, A.T. Kerigan, F.E. Hargreave, R. Chalmers, and J. Dolovich Late asthmatic responses induced by ragweed pollen allergen J Allergy Clin Immunol 54 1974 244 254
4. S.J. Galli, M. Tsai, and A.M. Piliponsky The development of allergic inflammation Nature 454 2008 445 454
5. C. Laprise, M. Laviolette, M. Boutet, and L.P. Boulet Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling Eur Respir J 14 1999 63 73
6. P. Nair, M.M. Pizzichini, M. Kjarsgaard, M.D. Inman, A. Efthimiadis, E. Pizzichini, and et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N Engl J Med 360 2009 985 993
7. P. Haldar, C.E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, A. Sousa, and et al. Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
8. B. Lamkhioued, P.M. Renzi, S. bi-Younes, E.A. Garcia-Zepada, Z. Allakhverdi, O. Ghaffar, and et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation J Immunol 159 1997 4593 4601
9. P.D. Collins, S. Marleau, D.A. Griffiths-Johnson, P.J. Jose, and T.J. Williams Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo J Exp Med 182 1995 1169 1174
10. A.W. Mould, K.I. Matthaei, I.G. Young, and P.S. Foster Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice J Clin Invest 99 1997 1064 1071
11. M. Kitaura, T. Nakajima, T. Imai, S. Harada, C. Combadiere, H.L. Tiffany, and et al. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3 J Biol Chem 271 1996 7725 7730
12. D.A. Griffiths-Johnson, P.D. Collins, A.G. Rossi, P.J. Jose, and T.J. Williams The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo Biochem Biophys Res Commun 197 1993 1167 1172
13. P.J. Jose, D.A. Griffiths-Johnson, P.D. Collins, D.T. Walsh, R. Moqbel, N.F. Totty, and et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation J Exp Med 179 1994 881 887
14. P.J. Jose, I.M. Adcock, D.A. Griffiths-Johnson, N. Berkman, T.N. Wells, T.J. Williams, and et al. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs Biochem Biophys Res Commun 205 1994 788 794
15. U. Forssmann, M. Uguccioni, P. Loetscher, C.A. Dahinden, H. Langen, M. Thelen, and et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes J Exp Med 185 1997 2171 2176
16. J.R. White, C. Imburgia, E. Dul, E. Appelbaum, K. O'Donnell, D.J. O'Shannessy, and et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils J Leukoc Biol 62 1997 667 675
17. A. Shinkai, H. Yoshisue, M. Koike, E. Shoji, S. Nakagawa, A. Saito, and et al. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils J Immunol 163 1999 1602 1610
18. M. Kitaura, N. Suzuki, T. Imai, S. Takagi, R. Suzuki, T. Nakajima, and et al. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3 J Biol Chem 274 1999 27975 27980
19. P.D. Ponath, S. Qin, T.W. Post, J. Wang, L. Wu, N.P. Gerard, and et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils J Exp Med 183 1996 2437 2448
20. B.L. Daugherty, S.J. Siciliano, J.A. DeMartino, L. Malkowitz, A. Sirotina, and M.S. Springer Cloning, expression, and characterization of the human eosinophil eotaxin receptor J Exp Med 183 1996 2349 2354
21. E. Frigas, D.A. Loegering, and G.J. Gleich Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium Lab Invest 42 1980 35 43
22. K. Hisamatsu, T. Ganbo, T. Nakazawa, Y. Murakami, G.J. Gleich, K. Makiyama, and et al. Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro J Allergy Clin Immunol 86 1990 52 63
23. V. Provost, M.C. Larose, A. Langlois, M. Rola-Pleszczynski, N. Flamand, and M. Laviolette CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2 J Leukoc Biol 94 2013 213 222
24. M. Lam, L. Hull, R. McLachlan, K. Snidvongs, D. Chin, E. Pratt, and et al. Clinical severity and epithelial endotypes in chronic rhinosinusitis Int Forum Allergy Rhinol 3 2013 121 128
25. S. Kagami, T. Kakinuma, H. Saeki, Y. Tsunemi, H. Fujita, K. Nakamura, and et al. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis Clin Exp Immunol 134 2003 309 313
26. C. Blanchard, N. Wang, K.F. Stringer, A. Mishra, P.C. Fulkerson, J.P. Abonia, and et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis J Clin Invest 116 2006 536 547
27. M.R. Konikoff, C. Blanchard, C. Kirby, B.K. Buckmeier, M.B. Cohen, J.E. Heubi, and et al. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis Clin Gastroenterol Hepatol 4 2006 1328 1336
28. K. Polzer, T. Karonitsch, T. Neumann, G. Eger, C. Haberler, A. Soleiman, and et al. Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activity Rheumatology (Oxford) 47 2008 804 808
29. N. Bhardwaj, and G. Ghaffari Biomarkers for eosinophilic esophagitis: a review Ann Allergy Asthma Immunol 109 2012 155 159
30. A. Vaglio, C. Buzio, and J. Zwerina Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art Allergy 68 2013 261 273
31. J.M. Coleman, C. Naik, F. Holguin, A. Ray, P. Ray, J.B. Trudeau, and et al. Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset Thorax 67 2012 1061 1066
32. V. Provost, A. Langlois, F. Chouinard, M. Rola-Pleszczynski, J. Chakir, N. Flamand, and et al. Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells PLoS One 7 2012 e43544
33. S.K. Saha, M.A. Berry, D. Parker, S. Siddiqui, A. Morgan, R. May, and et al. Increased sputum and bronchial biopsy IL-13 expression in severe asthma J Allergy Clin Immunol 121 2008 685 691
34. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986 Am Rev Respir Dis 136 1987 225 244
35. J. Chakir, N. Page, Q. Hamid, M. Laviolette, L.P. Boulet, and M. Rouabhia Bronchial mucosa produced by tissue engineering: a new tool to study cellular interactions in asthma J Allergy Clin Immunol 107 2001 36 40
36. F. Goulet, L.P. Boulet, J. Chakir, N. Tremblay, J. Dube, M. Laviolette, and et al. Morphologic and functional properties of bronchial cells isolated from normal and asthmatic subjects Am J Respir Cell Mol Biol 15 1996 312 318
37. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta C(T)) method Methods 25 2001 402 408
38. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
39. R. Thomsen, C.A. Solvsten, T.E. Linnet, J. Blechingberg, and A.L. Nielsen Analysis of qPCR data by converting exponentially related Ct values into linearly related X0 values J Bioinform Comput Biol 8 2010 885 900
40. I. Pin, P.G. Gibson, R. Kolendowicz, A. Girgis-Gabardo, J.A. Denburg, F.E. Hargreave, and et al. Use of induced sputum cell counts to investigate airway inflammation in asthma Thorax 47 1992 25 29
41. E. Pizzichini, M.M. Pizzichini, A. Efthimiadis, S. Evans, M.M. Morris, D. Squillace, and et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements Am J Respir Crit Care Med 154 1996 308 317
42. S. van Wetering, S. Zuyderduyn, D.K. Ninaber, M.A. van Sterkenburg, K.F. Rabe, and P.S. Hiemstra Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13 Mol Immunol 44 2007 803 811
43. A. Komiya, H. Nagase, H. Yamada, T. Sekiya, M. Yamaguchi, Y. Sano, and et al. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells Cell Immunol 225 2003 91 100
44. M. Paplinska-Goryca, P. Nejman-Gryz, R. Chazan, and H. Grubek-Jaworska The expression of the eotaxins IL-6 and CXCL8 in human epithelial cells from various levels of the respiratory tract Cell Mol Biol Lett 18 2013 612 630
45. B.O. Abonyo, M.S. Alexander, and A.S. Heiman Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation Am J Physiol Lung Cell Mol Physiol 289 2005 L478 L488
46. C.J. Duncan, A. Lawrie, M.G. Blaylock, J.G. Douglas, and G.M. Walsh Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Eur Respir J 22 2003 484 490
47. E. Truyen, L. Coteur, E. Dilissen, L. Overbergh, L.J. Dupont, J.L. Ceuppens, and et al. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients Thorax 61 2006 202 208
48. R. Louis, L.C. Lau, A.O. Bron, A.C. Roldaan, M. Radermecker, and R. Djukanovic The relationship between airways inflammation and asthma severity Am J Respir Crit Care Med 161 2000 9 16
49. C. Lemiere, P. Ernst, R. Olivenstein, Y. Yamauchi, K. Govindaraju, M.S. Ludwig, and et al. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes J Allergy Clin Immunol 118 2006 1033 1039
50. C. Blanchard, M.K. Mingler, M. Vicario, J.P. Abonia, Y.Y. Wu, T.X. Lu, and et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids J Allergy Clin Immunol 120 2007 1292 1300
51. M.A. Berry, D. Parker, N. Neale, L. Woodman, A. Morgan, P. Monk, and et al. Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis J Allergy Clin Immunol 114 2004 1106 1109
52. S.W. Park, H.K. Jangm, M.H. An, J.W. Min, A.S. Jang, J.H. Lee, and et al. Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparison with asthma Chest 128 2005 1921 1927
53. C.E. Brightling, F.A. Symon, S.T. Holgate, A.J. Wardlaw, I.D. Pavord, and P. Bradding Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma Clin Exp Allergy 33 2003 1711 1716
54. T. Naseer, E.M. Minshall, D.Y. Leung, S. Laberge, P. Ernst, R.J. Martin, and et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy Am J Respir Crit Care Med 155 1997 845 851
55. A. Shikotra, D.F. Choy, C.M. Ohri, E. Doran, C. Butler, B. Hargadon, and et al. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma J Allergy Clin Immunol 129 2012 104 111
56. M. Wills-Karp Interleukin-13 in asthma pathogenesis Immunol Rev 202 2004 175 190
57. G. Pelaia, A. Vatrella, and R. Maselli The potential of biologics for the treatment of asthma Nat Rev Drug Discov 11 2012 958 972
58. M.C. Catley, J. Coote, M. Bari, and K.L. Tomlinson Monoclonal antibodies for the treatment of asthma Pharmacol Ther 132 2011 333 351
59. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, J.R. Arron, and et al. Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
60. C. Blanchard, S. Durual, M. Estienne, S. Emami, S. Vasseur, and J.C. Cuber Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6 Int J Biochem Cell Biol 37 2005 2559 2573
61. S. Kagami, H. Saeki, M. Komine, T. Kakinuma, Y. Tsunemi, K. Nakamura, and et al. Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells Clin Exp Immunol 141 2005 459 466
62. R.E. Mullings, S.J. Wilson, S.M. Puddicombe, J.L. Lordan, F. Bucchieri, R. Djukanovic, and et al. Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium J Allergy Clin Immunol 108 2001 832 838
63. L. Zhou, T. Kawate, X. Liu, Y.B. Kim, Y. Zhao, G. Feng, and et al. STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells Bioorg Med Chem 20 2012 750 758
64. D. Hebenstreit, P. Luft, A. Schmiedlechner, A. Duschl, and J. Horejs-Hoeck SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells Mol Immunol 42 2005 295 303
65. E. Lim, and M.E. Rothenberg Demethylation of the human eotaxin-3 gene promoter leads to the elevated expression of eotaxin-3 J Immunol 192 2014 466 474
66. P.J. Barnes Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease J Allergy Clin Immunol 131 2013 636 645